We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 06, 2020

Bosutinib for Pretreated Patients With Chronic-Phase CML

Leukemia

 

Additional Info

Leukemia
Bosutinib for Pretreated Patients With Chronic Phase Chronic Myeloid Leukemia: Primary Results of the Phase 4 BYOND Study
Leukemia 2020 Jun 22;[EPub Ahead of Print], A Hochhaus, C Gambacorti-Passerini, C Abboud, BT Gjertsen, TH Brümmendorf, BD Smith, T Ernst, P Giraldo-Castellano, U Olsson-Strömberg, S Saussele, N Bardy-Bouxin, A Viqueira, E Leip, TA Russell-Smith, J Leone, G Rosti, J Watts, FJ Giles

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading